KTERMS

Go link

The society aims to stimulate research and development in the field of tissue engineering and regenerative medicine through collaborations and networking with national and international organizations. KTERMS also provides educational programs and encourages young scientists to engage in research in the field.

KTERMS hosts an annual congress where researchers and experts gather to share their knowledge and progress in the field of tissue engineering and regenerative medicine. The society also publishes a scientific journal called the Journal of Korean Tissue Engineering and Regenerative Medicine Society (JKTERMS), which is a peer-reviewed journal that publishes research papers, reviews, and editorials in the field.

The KTERMS has contributed significantly to the development of tissue engineering and regenerative medicine in South Korea, and it continues to play a vital role in the advancement of the field.

Greetings

Dear members and colleagues,

With the year of 2023 looming just around the corner, I wish you and your family a peaceful, healthy new year.

I would like to begin with my sincere appreciation to the 18 honorary presidents and fellow members of the Korean Tissue Engineering and Regenerative Medicine Society (KTERMS) for their devotion to the development of the society from its foundation in 1999 to establishment as an international society. The KTERMS successfully hosted three TERMIS conferences on both the world and regional levels, most recently in October 2022 for the Asia-Pacific edition held in Jeju, while continuing to provide members with ample didactical, networking opportunities via academic conferences, educational symposiums, and symposiums for emerging researchers.

This year, equipped with confidence from the past success, the society is seeking to further solidifying the society’s position in the field of tissue engineering and regenerative medicine by facilitating application of the achievements made in the basic and translational research into the clinical setting. We will continue to encourage more clinical experts to participate in the conferences that, we hope, will aid members to build and expand the networks pivotal to clinical application of translational medicine research. In accordance with the recent effort, the honorary presidents So Ra Park and In Ho Jo have tirelessly worked for the development in the academic domain, serving the roles as the heads of the Regenerative Medicine Acceleration Foundation and the Korean Fund for Regenerative Medicine. I would like to express my sincere appreciation for their provision of the practical assistance to members through programs such as the Advanced Regenerative Medical Education Forum.

Tissue Engineering and Regenerative Medicine, the society’s journal founded in 2004, has established itself as an SCIE-indexed, internationally recognized, prestigious academic journal in the field of tissue engineering and regenerative medicine, thanks to the dedicated works of former and current editors-in-chief Young Sook Son, Byoung Hyun Min, Chong-Su Cho, and In Ho Jo. The impact factor saw a notable growth, the latest being 4.451, in comparison to the previous 0.345 in 2012 and 2.272 in 2018. The success is by virtue of the endeavors of the editors-in-chief, associate editors, reviewers, and, most importantly, of each member by submission of manuscripts over the years.

Through the industry-academic cooperation committee and the symposiums for emerging researchers that began in 2019 and 2021 respectively, our research colleagues were able to jointly re-define the notion of unmet medical needs, prioritizing the pressing patient and societal needs in our field, which enabled the production of results more relevant and directly beneficial to the intended patient population. Furthermore, owing to the valuable contributions of our peer investigators, we witnessed the establishment of the necessary infrastructures and subsequent expansion of regenerative medicine as an industry both domestically and internationally. I am confident that the next generation of researchers will take on the role to continue to build on this legacy.

As we transition from the pandemic era, I believe more in-person academic events will be held this year, which will facilitate unhindered member interaction. Please do not hesitate—in fact, I highly encourage—to reach out to the society should you be interested in joining a committee, presenting at a conference, or providing valuable feedbacks. Your active participation in any given domain of the society is highly appreciated! I look forward to another year of your unwavering interest and continued support, and sincerely hope that all your wishes for the new year be fulfilled.

With many thanks and warmest regards,

Seung-Yup Ku

January, 2023

President

Korean Tissue Engineering and Regenerative Medicine Society

Seung-Yup Ku, M.D., Ph.D.

Introduction

  • - About the KTERMS

    The Korean Tissue Engineering and Regenerative Medicine Society (as known as KTERMS) was establish on 1999 in order to contribute to promotion of science and medicine by development and dissemination of academics and technologies related to “Tissue engineering and Regenerative medicine”.

  • - Major Business
    • • Hold annual academic conferences, research presentations, lectures and exhibition, etc.
    • • Publication of journal and articles
    • • Research and Data collection
    • • Encouragement of research and commendation for outstanding achievements
    • • Liaison and cooperation with related domestic/international associations.
    • • Sponsorship of public work projects, Advice and suggest on Tissue Engineering and Regenerative Medicine
    • • International Exchange for academics
    • • Other projects necessary to achieve the purpose of this association
  • - Chronicles
    • 1999 1st Tissue Engineering Symposium @ National Institute of Health, Korea
    • 2000 2nd Tissue Engineering Symposium @ National Institute of Health, Korea
    • 2001 General Meeting and 3rd Tissue Engineering Symposium
    • 2002 4th KTERMS General Meeting and Research Journal presentation, @ Korea Research Instituted of Chemical Technology
    • 2003 5th KTERMS General Meeting and Research Journal Presentation @ Seoul, The Catholic University of Korea
    • 2003 1st KOREA-JAPAN Joint Symposium
    • 2004 Publication for Academic Journal ‘Tissue Engineering and Regenerative Medicine (TERM)”
    • 2004 6th KTERMS General Meeting, Research Journal Presentation @ Suwon, Ajou University Hospital
    • 2005 TERMIS-AP Launch and 1st general meeting
    • 2005 7th KTERMS General Meeting, Research Journal Presentation @ Seoul, The Catholic University of Korea
    • 2006 8th KTERMS General Meeting, Research Journal Presentation @ Seoul, Sungkyunkwan University
    • 2007 9th General Meeting, Research Journal Presentation @ Seoul, Seoul National University
    • 2008 KTERMS 10 YEARS ANNIVERSARY CEREMONY & General Meeting, Research Journal Presentation @ Seoul, Dongguk University
    • 2008 'Tissue Engineering and Regenerative Medicine(TERM)' was candidate for SCI(E) and KCI, Listed in SCOPUS as well. Imfact Factor 3.158 (2009)
    • 2009 TERMIS-WC 2009 @ Seoul, Jamsil Lotte Hotel
    • 2010 12th KTERMS Conference @ Seoul Saint Mary hospital.
    • 2010 1st KTERMS Education Symposium @ Seoul Saint Mary hospital.
    • 2011 13th KTERMS Conference @ The Catholic University of Korea
    • 2011 2nd KTERMS Education Symposium @ Seoul Saint Mary hospital
    • 2012 14th KTERMS Conference @ Seoul Saint Mary Hospital
    • 2012 3rd KTERMS Education Symposium @ Seoul Saint Mary Hospital
    • 2012 Issue the Textbook for ‘Tissue Engineering Regenerative Medicine Experiment;
    • 2013 15th KTERMS Conference @ Seoul, ST Center
    • 2013 4th KTERMS Education Symposium @ Seoul, ST Center
    • 2014 TERMIS-AP 2014 @ Daegu, Dexco
    • 2014 5th KTERMS Education Symposium @ Seoul, The Catholic University of Korea
    • 2015 16th KTERMS Conference @ Seoul, The Catholic University of Korea
    • 2015 6th KTERMS Education Symposium @ Seoul, The Catholic University of Korea
    • 2016 17th KTERMS Conference @ Seoul, Ewha Womens University ECC
    • 2016 7th KTERMS Education Symposium @ Pangyo, CHA Bio-Complex
    • 2017 18th KTERMS Conference @ Daegu, Kyungpook University Global Plaza
    • 2017 8th KTERMS Education Symposium @ Seoul, The Catholic University of Korea
    • 2018 19th KTERMS Conference @ KIST
    • 2018 9th KTERMS Education Symposium @ Seoul, The Catholic University of Korea
    • 2019 20th KTERMS Conference @ ICC Jeju
    • 2019 10th KTERMS Education Symposium @ Seoul, The Catholic University of Korea
    • 2019 KTERMS Chung-chung District Symposium @Daejeon, Hannam University Daedeok Valley Campus
    • 2019 Listed in PubMed Central for 'Tissue Engineering and Regenerative Medicine(TERM)'
    • 2020 21th KTERMS Conference @ Online
    • 2020 12th KTERMS Education Symposium @ Online
    • 2021 1st KTERMS Young Investigator Symposium @ Online
    • 2021 22th KTERMS Conference @ Online
    • 2021 12th KTERMS Education Symposium @ Seoul National University GECC
    • 2022 2nd KTERMS Young Investigator Symposium and General Meeting @ CHA Bio-complex
    • 2022 TERMIS-AP 2022 @ ICC Jeju
    • 2022 13th KTERMS Education Symposium @ Pangyo, CHA Bio-Complex
    • 2023 23th KTERMS conference @ Seoul National University Hospital (Scheduled)
    • 2023 2nd KTERMS Young investigator Symposium @ Seoul National University Hospital (Scheduled)
    • 2023 14th KTERMS Education Symposium @ TBC (Scheduled)

Organization

Executive Member

  • Hae Bang Lee, Ph.D.

    • Ajou University
  • Jung Man Kim

    • Asan Chungmu Hospital
  • Kwang Won Kim

    • Gacheon Univ.
  • Chong-Su Cho, Ph.D. 

    • Seoul National University
  • Shin Yong Moon, M.D., Ph.D.

    • M Fertility Clinic
  • Jung-Keug Park

    • Dongguk Univ.
  • Il Woo Lee, M.D., Ph.D.

    • Catholic University
  • Shin Yoon Kim

    • Kyungbook National Univ.
  • Soo Hyun Kim

    • KIST
  •  Jin Ho Lee, Ph.D. 

    • Hannam University
  • Byung Hyun Min, M.D., Ph.D. 

    • Ajou University
  • Jeong Ok Lim, Ph.D. 

    • Kyungbook National University
  • Jong Won Lee, M.D., Ph.D.

    • Catholic University
  • Inho Jo, Ph.D. 

    • Ewha Women's University
  • So Ra Park, M.D., Ph.D.

    • Inha University
  • Dong Keun Han, Ph.D.

    • Cha University
  • Gun-Il Im, M.D., Ph.D.  

    • Dongguk University
  • Moon Suk Kim, Ph.D.

    • Ajou University

Introduction

AIMS AND SCOPE

Tissue Engineering and Regenerative Medicine (TERM) is the official journal of the Korean Tissue Engineering and Regenerative Medicine Society and is published bimonthly on the 1st of February, April, June, August, October, and December. The journal has the aim of publication dedicated to providing research-based solutions to human diseases. It is a peer-reviewed journal that publishes research papers, reviews, and features in the fields of tissue engineering, medical biomaterials, cell therapy, stem cell biology, and regenerative medicine. The journal is covering a wide array of issues in polymer chemistry, natural science, engineering, molecular biology, genomics, cell biology, cytology, medical science, and preclinical and clinical studies. Organ and tissue regeneration include brain and nervous system, cardiovascular system, skeletal muscle, bone and bone marrow.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline/Pubmed, PubMed Central, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, CNKI, EBSCO Discovery Service, EI Compendex, OCLC WorldCat Discovery Service, ProQuest Central, ProQuest Research Library, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys

Editorial Committee (Renewed on April-01-2023)
Editor-in-Chief

Inho Jo, Ph.D. (Ewha Womans University, Korea)

Senior Editor

Chong-Su Cho, Ph.D. (Seoul National University, Korea)

Regional Associate Editors

Europe : Jöns Hilborn, Ph.D. (Uppsala University, Sweden)

Asia : James Goh, Ph.D. (National University of Singapore, Singapore)

North America : James J. Yoo, M.D., Ph.D. (Wake Forest University, U.S.A.)

Oceania: Justin Cooper-White, Ph.D. (Univ. of Queensland, Australia)

Associate Editors

Biomaterials & Tissue Engineering : Jeong Ok Lim, Ph.D. (Kyungpook National University, Korea)

Biomaterials & Tissue Engineering : Se Heang Oh, Ph.D. (Dankook University, Korea)

Biomaterials & Tissue Engineering : Young-Kwon Seo, Ph.D. (Dongguk University, Korea)

Cell Biology & Stem Cell : Byung Hyune Choi, Ph.D. (Inha University, Korea)

Cell Biology & Stem Cell : Han-Soo Kim, Ph.D. (Catholic Kwandong University, Korea)

Cell Biology & Stem Cell : Seung Yup Ku, M.D., Ph.D. (Seoul National University, Korea)

Cell Biology & Stem Cell : Eui Kyun Park, Ph.D. (Kyungpook National University, Korea)

Regenerative Medicine & Clinical Investigation : Jun-Ho Byun, D.D.S., Ph.D. (Gyeongsang Nationall University, Korea)

Regenerative Medicine & Clinical Investigation : Hyuk-Soo Han, M.D., Ph.D. (Seoul National University, Korea)

Regenerative Medicine & Clinical Investigation : Sung Won Kim, M.D., Ph.D. (The Catholic University of Korea, Korea)

Regenerative Medicine & Clinical Investigation : Jang Hyun Lee, M.D., Ph.D. (Hanyang University, Korea)

Social Media Editor

Yoon Young Kim, Ph.D. (Medical Research Center, Seoul Nat'l Univ., Korea)

Editorial Board:

Suk Ho Bhang, Ph.D. (School of Chemical Engineering, Sungkyunkwan Univ., Korea)

Young Woo Cheon, M.D. Ph.D. (Dept. of Plastic & Reconstructive Surgery, Gachon Univ. College of Medicine, Korea)

Myung Soo Cho, Ph.D. (Dept. of TED, S.Biomedics Co. Ltd., Korea)

Seung-Woo Cho, Ph.D. (Dept. of Biotechnology, Yonsei Univ., Korea)

Heung Jae Chun, Ph.D. (Institute of Cell & Tissue Engineering, The Catholic Univ. of Korea, Korea)

Dong Keun Han, Ph.D. (Dept. of Biomedical Science, CHA Univ., Korea)

Changmo Hwang, Ph.D. (Dept. of Convergence Medicine, Univ. of Ulsan College of Medicine, Korea)

Nathaniel S. Hwang, Ph.D. (Institute for Chemical Processing, Seoul Nat'l Univ., Korea)

Wooyoung Jeong, Ph.D. (Dept. of Biomedical Engineering, Catholic Kwandong Univ., Korea)

Chris Hyunchul Jo, M.D. (Ph.D., Dept. of Orthopedic Surgery, Seoul Nat'l Univ., Korea)

Youngmee Jung, Ph.D. (Biomaterials Research Center, KIST, Korea)

Byung-Soo Kim, Ph.D. (School of Chemical and Biological Engineering, Seoul Nat'l Univ., Korea)

Chun Ho Kim, Ph.D. (Tissue Engineering Lab., KIRAMS, Korea)

Han Su Kim, M.D., Ph.D. (Dept. of Otorhinolaryngology-Head & Neck Surgery, Ewha Womans Univ., Korea)

Jong Hoon Kim, Ph.D. (College of Life Sciences and Biotechnology, Korea Univ., Korea)

Jong Young Kim, Ph.D. (Dept. of Mechanical Engineering, Andong Nat'l Univ., Korea)

Moon Suk Kim , Ph.D. (Dept. of Molecular Science & Tech., Ajou Univ., Korea)

Sang Hun Kim, Ph.D. (Biomaterials Research Center, KIST, Korea)

Soo Hyun Kim, Ph.D. (Biomaterials Research Center, KIST, Korea)

Soon Hee Kim, Ph.D. (Nano Bio Regenerative Medical Institute, Hallym Univ., Korea)

Yong Jin Kim, M.D., Ph.D. (Dept. of Obstetrics and Gynecology, Korea Univ., Korea)

Oh Hyeong Kwon, Ph.D. (Dept. of Polymer Science and Engineering, Kumoh Nat'l Institute of Technology, Korea)

Tae Gyun Kwon, M.D., Ph.D. (Dept of Urology, Kyungpook Nat'l Univ., Korea)

EunAh Lee, Ph.D. (Impedance Imaging Research Center, Kyung Hee Univ., Korea)

Sang Cheon Lee, Ph.D. (School of Dentistry, Kyung Hee Univ., Korea)

Kun Na, Ph.D. (Dept. of Biotechnology, The Catholic Univ. of Korea, Korea)

Insup Noh, Ph.D. (Dept. of Chemical and Biomolecular Engineering, Seoul Nat'l Univ. of Tech., Korea)

Hyun Sook Park, Ph.D. (CEFO Co., Ltd, Korea)

In Kyu Park, Ph.D. (Dept. of Biomedical Sciences, Chonnam Nat'l Univ., Korea)

Kwi Deok Park, Ph.D. (Biomaterials Research Center, KIST, Korea)

Sang Hyug Park , Ph.D. (Dept. of Biomedical Engineering, Pukyong Nat'l Univ., Korea)

Yong-Beom Park, M.D., Ph.D. (Division of Rheumatology, Yonsei Univ., Korea)

Jung Wook Shin, Ph.D. (Dept. of Biomedical Engineering, Inje Univ., Korea)

Hee Seok Yang, Ph.D. (Dept. of Nanobiomedical Science, Dankook Univ., Korea)

Jeong Joon Yoo, M.D., Ph.D. (Dept. of Orthopedic Surgery, Seoul Nat'l Univ., Korea)

Jong Pil Yoon, M.D., Ph.D. (Dept. of Orthopedic Surgery, Kyungpook Nat'l Univ., Korea)

International Editorial Board:

Toshihiro Akaike, Ph.D. (Tokyo Institute of Technology Japan, Japan)

Ahnond Bunyaratvej, Ph.D. (Mahidol University, Thailand)

Yilin Cao, Ph.D. (Shanghai 9th Hospital, China)

Guoping Chen, Ph.D. (National Inst. Material & Science, Japan)

Akon Higuchi, Ph.D. (National Central University, Taiwan)

Ging-Ho Hsiue, Ph.D. (National Tsinghua University, Taiwan)

Yu-Chen Hu, Ph.D. (Nationall Tsing Hua University, Taiwan)

John D. Jackson, Ph.D. (Wake Forest University, U.S.A.)

R. Jayakumar, Ph.D. (Amrita Institute of Medical Science & Research Centre, India)

Sang Jin Lee, Ph.D. (Wake Forest University, U.S.A.)

Wei Liu, M.D., Ph.D. (Shanghai Jiao Tong University, China)

Teruo Okano, Ph.D. (TWMU, Japan)

Uthra Rajamani, Ph.D. (Cedars Sinai Medical Center, U.S.A.)

Allan J. Russell, Ph.D. (Past-President of TERMIS, Carnegie Mellon Univ., U.S.A.)

Binti Haji Idrus Ruszymah, M.D., Ph.D. (University of Kebangsaan, Malaysia)

Jan-Thorsten Schantz, M.D., Ph.D. (Technical University of Munich, Germany)

Minuro Ueda, D.D.S., Ph.D. (Nagoya University, Japan)

Salvatore Giovanni Vitale, M.D., Ph.D. (University of Catania, Italy)

Xiumei Wang, Ph.D. (Tsinghua University, China)

Managing Editor:

Jung Hyun Ahn (Korean Tissue Engineering and Regenerative Medicine Society, Korea)

More information about ‘TERM’
Editorial Office

1414 Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 06732, Korea

Tel: +82-70-7558-2608 Fax: +82-70-8258-2608 E-mail: kterms.edit@gmail.com

Guidelines

Instructions for Authors

Tissue Engineering and Regenerative Medicine (Tissue Eng Regen Med, TERM), the official journal of the Korean Tissue Engineering and Regenerative Medicine Society, is a publication dedicated to providing research- based solutions to issues related to human diseases. This journal publishes articles that report substantial information and original findings on tissue engineering, medical biomaterials, cells therapy, stem cell biology and regenerative medicine. Manuscript for submission should be prepared according to the following instructions. For policies unstated in this instruction, the Uniform Requirements for Manuscripts Submitted to Biomedical journals: Writing and Editing for Biomedical Publication (http://www.icmje.org/) can be applied.

Submission of Manuscripts

All manuscripts must be submitted online via the journal’s website (http://www.editorialmanager.com/term/) by the corresponding author. TERM publishes feature articles, review articles, editorials and original research articles. Feature articles and editorials are invited only by editors. As occasional demands, the journal also publishes technical note, conference report and introduction of research centers.(The editorial office: Korean Tissue Engineering and Regenerative Medicine Society, 1414 Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 06732, Korea, Tel: +82-70-7558-2608, Fax: +82-70-8258-2608, Email: kterms.edit@gmail.com).

Journal Policies and Publication Ethics

Duplicated Publication The papers already published to other scientific journals or periodicals are not considered for publication as an original research article. Exceptions are allowed for conference abstracts and short proceedings. The submitted manuscripts to TERM should not be submitted to other scientific journal during the review process.

Authorship The authorship should be restricted to those who should meet any of the following conditions: 1) substantial contribution to the conception and design of the study, or acquisition, interpretation and analysis of data; 2) drafting the article or revising it critically for the important intellectual content; and 3) final approval of the version to be published. The corresponding author should declare the role each author according to the above criteria in the submitted manuscript.

Statement of Human and Animal Rights All human and animal investigations must be conducted according to the principles expressed in the Declaration of Helsinki. All studies involving research conducted in human and animal subjects must include a statement both in the Materials and Methods section and the Ethical statement section indicating approval by the institutional review board. Patients details may be included only if they are essential for scientific purposes and the authors obtain written informed consent for publication form the patient, pares, or guardian. Manuscripts without using human subjects and experimental animals should also declare that they have no ethical issues for human and animal right in the Ethical statement section.

Conflicts of Interest All authors must disclose any commercial affiliations or consultancies, stock or equity interests, or patent-licensing arrangements that could be considered to pose a conflicts of interest regarding the submitted manuscript. Potential conflicts of interest must be described in the Conflicts of interest section. If there are no potential financial conflicts of interest, please add the following statement: “The authors have no financial conflicts of interest.” All funding sources, institutional and corporate should be credited in the Acknowledgments section. For policies unstated on the research and publication ethics not stated in this instructions, International Standards for Editors and Authors (http://publicationethics.org/international-standards-editors-and-authors) can be applied

Copyrights Copyrights of all published materials are owned by the Korean Tissue Engineering and Regenerative Medicine Society and all materials must not be published elsewhere without written permission. All authors must sign the “Copyright Transfer Agreement” before the article can be published and submit at the time of manuscript submission.

Peer Review Process

Manuscripts are peer-reviewed by at least 2 anonymous reviewers selected confidentially by the editors. Selected reviewers are not supposed to be involved in the submitted works or in personal relationship with the authors. The acceptance criteria for all papers are based on the quality and originality of the research and its scientific significance. An initial decision will normally be made within 3 weeks after the agreement of review by the reviewers, and the review’s comments will then be sent to the corresponding authors. The author is then notified of Editor-in-chief’s decision to accept, reject, or request the revision of the manuscript. For manuscripts that need revision, the authors are recommended to submit the revised manuscript within 8 weeks for major revision and 1 week for minor revision of the decision date. The revision process can be extended on prior demand. Rejected papers will not be peer-reviewed again, unless it is substantially modified before resubmission.

Manuscript Preparation

The main document with the manuscript text and tables should be prepared with an MS Word in proper and clear English. The manuscript text should be written in double spaced, 12-point font, preferably Times New Roman on A4 sized paper with 2.5 cm margins on the top, bottom, right, and left. Authors should be limit the use of abbreviations to a minimum. Abbreviations are not to be used in titles. Abstracts may contain abbreviations for terms mentioned many times in the Abstract, but each abbreviation must be defined the first time it is used. Drug and chemical names should be stated in standard chemical or generic nomenclature. Units of measure should be presented according to the International System (SI) of Units. All units must be preceded by one space except percentage (%) and temperature (°C). Descriptions of genes or related structures in a manuscript should include the names and official symbols provided by the US National Center for Biotechnology Information (NCBI) or the HUGO Gene Nomenclature Committee. Of generic and brand name of medicine, use generic names. If a brand name should be used, insert it in parentheses after the generic name.

Original article Manuscripts should be divided into the following sections; Title page, Abstract, Main text (Introduction, Materials and Methods, Results, Discussion), Acknowledgments, Conflicts of Interest, Ethical Statement, References, Tables, and Figure legends.

Title page This should contain the title and running title of the article and the full names and affiliations of all authors. If several authors and institutions are listed, it should be clearly indicated with which department and institution each author is affiliated as a superscript after each author’s last name. In a separate paragraph, an address for correspondence, including the name of corresponding author, academic degree, address (institutional affiliation, city, zip code and country), telephone numbers, and email address (if present), should be given. Place an asterisk (*) after the name of the corresponding. The title should be concise and descriptive, should comprise fewer than 100 characters. A running title of fewer than 60 characters should be included.

Abstract The abstract should be structured such as ‘BACKGROUND’, ‘METHODS’, ‘RESULTS’, ‘CONCLUSION’ and its length should be 200-250 words. Authors must provide 3-5 key words for indexing purposes. For the selection of key words, refer to Medical Subject Headings (MeSH) in Index Medicus, or at the internet site, http://www.nlm.nih.gov/mesh/MBrowser.html.

Main text Authors are urged to write as concisely as possible. The total length of a manuscript (including references and figure legends) should be fewer than 60,000 characters.

Acknowledgments, Conflicts of interest, Ethical Statement Please note the journal policies and publication ethics

Examples of Ethical statement: The study protocol was approved by the institutional review board of #### (IRB No. ##-##-###). Informed consent was confirmed (or waived) by the IRB. The animal studies were performed after receiving approval of the Institutional Animal Care and Use Committee (IACUC) in ### University (IACUC approval No. ##-##-###).

Citation Reference citations in the text should be identified by numbers in square brackets. Some examples:
1. Negotiation research spans many disciplines [3].
2. This result was later contradicted by Becker and Seligman [5].
3. This effect has been widely studied [1-3, 7].

Reference list References should be numbered consecutively in the order in which they are first mentioned in the text. Each reference should be cited as [1], [1,4], or [1-3]. The abbreviated journal title should be used according to the List of Journals Indexed for MEDLINE (http://www.ncbi.nlm. nih.gov/nlmcatalog/journals). References with six or fewer authors should list all of them, while those with seven or more authors should list only the first six, followed by ‘et al.’.
Reference to unpublished data and personal communications should appear in the text only. Other types of references not described below should follow Citing medicine: The NLM style guide for authors, editors, and publishers (http://www.ncbi.nlm.nih.gov/books/NBK7256/).
Sample references are given below: • Journal article
Jeong JH, Park J, Jin ES, Min J, Jeon SR, Kim DK, et al. Adipose tissue-derived stem cells in the ovariectomyinducedpostmenopausal osteoporosis rat model. Tissue Eng Regen Med 2015;12:22-8.
• Article by DOI
Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. J Mol Med. 2000; doi:10.1007/s001090000086
• Book
Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed.
Oxford: Blackwell Science; 1998.
• Book chapter
Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. pp. 251–306.
• Online document
Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.

Tables Tables should be typed double-spaced on separate pages within manuscript, and they should be titled and numbered in Arabic numerals in the order of their first citation in the text. Explanatory matter is placed in footnotes and not included in the title. Explain all abbreviations in the footnotes. Each column should have an appropriate heading, and if numerical measurements are given, the unit should be added to column headings. Footnotes should be indicated by superscripts (symbols).

Figures Figure legends should be typed double-spaced on a separate sheet following Figure 1 or Figure 2. Capital letters should be used for multiple parts of a single figure. Symbol, arrows and letters indicating parts of illustrations should be explained in the legend. Each figure should be referred in the text consecutively as Fig. 1 or Fig. 2A in parenthesis and should be numbered according to order of citation. There should be no more than 10 figure legends. Each figure should be submitted in a separate fi le, at a resolution of more than 300 dpi with a minimum width of 100 mm. Acceptable file formats are JPEG or TIFF. Line-arts (graphs and illustrations) should be submitted in native PPT (preferred) including editable figure elements, vector fi les (e.g., EPS) or TIFF fi les (at least 900 dpi with a minimum width of 100 mm). If you submit usable color figures then we will ensure, at no additional charge that these figures will appear in color on the Web (electronic version). For color reproduction in print, you will receive information regarding the costs after receipt of your accepted article. Please indicate your preference for color in print or on the Web only.

Supplementary data TERM accepts electronic supplementary material (e-components) to support and enhance your scientific research. Supporting data that are not essential for appreciating the conclusions made in a manuscript may be included as supplemental material. Examples of appropriate data for supplemental material include DNA sequences or Western blots that show the specificity of an antibody or efficient knockdown of a gene product. Supplementary fi les supplied will be published online alongside the electronic version of your article. In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended text and image fi le formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each fi le. The number of supplemental display items is limited to five for an article.

Feature article, Review article These articles are generally prepared in the same format as original articles, but the details of the manuscript format may be flexible according to the contents.

Proofs

Accepted manuscript will be converted to PDF format. The PDF fi le will be dispatched to the author for proofreading. Any change should be returned within 48 hours after receipt of the PDF fi les. No significant changes should be made to alter the interpretation of the results.

Publication Processing Charge

For unsolicited manuscripts, the author is asked to pay for a portion of the costs of article processing. The processing charge for one article is US $500 (500,000 Korean won). No article processing charge will be requested from authors outside of Korea in order to encourage active submission form throughout the world. This policy is subject to change in the future.

Research/Archive

Archive

회원가입 및 로그인을 하시면 논문 전문을 보실 수 있습니다.

2016년 이후 출판 논문은 PubMed Central 에서 열람하실 수 있습니다.

Submission

페이지 준비중 입니다.

 

Annual Meetings

Title Date Place
2023 KTERMS Conference 2023.05.19~05.20 Seoul, Seoul National University Hospital
2022 KTERMS Education Symposium 2022.12.09 Pangyo, CHA Bio-Complex
TERMIS-AP 2022 2022.10.05~10.08 International Convention Center JEJU
2022 KTERMS Young Investigator Symposium 2022.04.29 Pangyo, CHA Bio-Complex
2021 KTERMS Education Symposium 2021.11.26 Seoul,
Seoul National University Global Convention Plaza
2021 KTERMS Conference 2021.06.18~6.19 Online
2020 KTERMS Education Symposium 2020.11.20 Online
2020 KTERMS Conference 2020.08.28 Online
2019 KTERMS Education Symposium 2019.11.22 Seoul, The Catholic University of Korea
2019 KTERMS Symposium for Chung-Cheong 2019.07.24 Daejeon,
Hannam University DAEDEOK Valley Campus
2019 KTERMS Conference 2019.06.06~06.08 International Convention Center JEJU
2018 KTERMS Education Symposium 2018.11.23 Seoul, The Catholic University of Korea
2018 KTERMS Conference 2018.05.25~05.26 KIST
2017 KTERMS Education Symposium 2017.11.24 Seoul, The Catholic University of Korea
2017 KTERMS Conference 2017.06.02~06.03 Daegu, Kyungpook University Global Plaza
2016 KTERMS Education Symposium 2016.11.25 Pangyo, CHA Bio-Complex
2016 KTERMS Conference 2016.06.10~06.11 Seoul, Ehwa Womens University ECC
2015 KTERMS Education Symposium 2015.11.27 Seoul, The Catholic University of Korea
2015 KTERMS Conference 2015.05.29~5.30 Seoul, The Catholic University of Korea
2014 KTERMS Education Symposium 2014.06.27 Seoul, The Catholic University of Korea
TERMIS-AP 2014 2014.09.24~09.27 Daegu, Dexco

TERMIS

페이지 준비중 입니다.

 

How to join the KTERMS

  • - Membership

    The Korean Tissue Engineering and Regenerative Medicine Society (KTERMS) is a nonprofit organization of researchers, physicians, and students dealing with Tissue Engineering and Regenerative Medicine

  • - Benefits for KTERMS Membership

    Key Benefits for KTERMS membership include:

    • • Discount on the registration fee for the annual meeting, symposium, and workshop.
    • • Free download the published articles
    • • Opportunity to collaborate with KTERMS members (More than 3,500 members)
  • - Join KTERMS : View fees and become a member

    If you become a member of KTERMS, you can do so through the website (http://kterms.or.kr) and have to pay the annual fee. Members who pay annual fees can free download journal articles online and view the information provided to members from June 1st of the year to May 31st of the following year. When you register for conferences, symposiums, and workshops, you can be subject to a member rate.

    Annual Fee (WON)
    General Student
    KRW 50,000 KRW 30,000
  • - Contact

    For more information, contact kterms@gmail.com

Eductional Institution

Domestic

  • Kyungpook National University

International

  • University of Texas University of Texas
  • University of Washington’s ERC University of Washington’s ERC
  • JOHNS HOPKINS University JOHNS HOPKINS University
  • Cornell University Cornell University
  • University of California, UC San Diego University of California, UC San Diego
  • University of lllinois, at Chicago University of lllinois, at Chicago
  • University of Nottingham (UK Campus) University of Nottingham (UK Campus)
  • IZKF BIOMAT IZKF BIOMAT
  • OSAKA UNIVERSITY OSAKA UNIVERSITY

Organization

Domestic

  • Institute for Advanced Engineering Institute for Advanced Engineering
  • Statistics Korea Statistics Korea
  • Korean Intellectual Property Office Korean Intellectual Property Office
  • National Science Museum National Science Museum
  • Korea Institute of S&T Evaluation and Planning Korea Institute of S&T Evaluation and Planning
  • Korea Research Institute of Bioscience and Biotechnology Korea Research Institute of Bioscience and Biotechnology
  • Ministry of Health and Welfare Ministry of Health and Welfare
  • Ministry of Food and Drug Safety Ministry of Food and Drug Safety
  • REGENEATIVE MEDICINE ACCELERATION FOUNDATION REGENEATIVE MEDICINE ACCELERATION FOUNDATION
  • Regenerative Medical System (RMS) Regenerative Medical System (RMS)
  • DONG-A SOCIO HOLDINGS DONG-A SOCIO HOLDINGS
  • REGEN BIOTECH, INC REGEN BIOTECH, INC
  • CHO-A PHARM, CO. LTD. CHO-A PHARM, CO. LTD.
  • MEDI-POST MEDI-POST
  • TEGOSCIENCE TEGOSCIENCE
  • HANALL BIOPHARMA HANALL BIOPHARMA
  • WELSKIN WELSKIN

International

  • All about Grants All about Grants
  • FDA FDA
  • Advanced tissue Advanced tissue
  • Articular Engineering Articular Engineering
  • INTEGRA INTEGRA
  • BIOHEART BIOHEART
  • MatTek Corporation MatTek Corporation
  • Organogenesis Inc. Organogenesis Inc.
  • Osiris Therapeutics Inc. Osiris Therapeutics Inc.
  • OBI-Corporate Information OBI-Corporate Information
  • ETEX Corporation ETEX Corporation
  • REGEN Biologics, Inc. REGEN Biologics, Inc.
  • PubMed PubMed
  • Springer Link Springer Link

Society

Domestic

  • The Korean Society for Composite Materials The Korean Society for Composite Materials
  • Korean Society for Molecular and Cellular Biology Korean Society for Molecular and Cellular Biology
  • The Korean Society for Microbiology The Korean Society for Microbiology
  • The Korean Institute of Chemical Engineers The Korean Institute of Chemical Engineers
  • The Pharmaceutical Society of Korea The Pharmaceutical Society of Korea
  • The Korean Orthopaedic Association The Korean Orthopaedic Association
  • Korean Society of Plastic and Reconstructive Surgeons Korean Society of Plastic and Reconstructive Surgeons
  • Korean Society of Otorhinolaryngology-Head and Neck Surgery Korean Society of Otorhinolaryngology-Head and Neck Surgery
  • The Korean Neurosurgical Society The Korean Neurosurgical Society
  • Korean Chemical Society Korean Chemical Society
  • The Korean Society of Applied Pharmacology The Korean Society of Applied Pharmacology
  • The Polymer Society of Korea The Polymer Society of Korea
  • The Korean Society of Industrial and Engineering Chemistry The Korean Society of Industrial and Engineering Chemistry
  • Korean Society of Biochemistry and Molecular Biology Korean Society of Biochemistry and Molecular Biology
  • The Korean Society for Biomaterials The Korean Society for Biomaterials
  • The Korean Association of Oral and Maxillofacial Surgeons The Korean Association of Oral and Maxillofacial Surgeons
  • The Korean Society of Medical & Biological Engineering The Korean Society of Medical & Biological Engineering
  • Tissue Engineering and Regenerative Medicine International Society Tissue Engineering and Regenerative Medicine International Society
  • Orthopaedic Research Society Orthopaedic Research Society

International

  • Janpanese Society ofr Tissue Engineering Janpanese Society ofr Tissue Engineering
  • Society for Biomaterials (SFB) Society for Biomaterials (SFB)
  • Controlled Release Society Controlled Release Society

Office

Address 1414, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul, Republic of Korea 06732
Website http://www.kterms.or.kr
E-mail kterms@gmail.com
Tel. +82 70 7558 7508
Fax. +82 70 8258 2608